GB0121026D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0121026D0
GB0121026D0 GBGB0121026.9A GB0121026A GB0121026D0 GB 0121026 D0 GB0121026 D0 GB 0121026D0 GB 0121026 A GB0121026 A GB 0121026A GB 0121026 D0 GB0121026 D0 GB 0121026D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0121026.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0121026.9A priority Critical patent/GB0121026D0/en
Publication of GB0121026D0 publication Critical patent/GB0121026D0/en
Priority to ARP020103230A priority patent/AR036375A1/en
Priority to PL367821A priority patent/PL208280B1/en
Priority to JP2003524585A priority patent/JP4131701B2/en
Priority to AU2002333758A priority patent/AU2002333758B2/en
Priority to CN028169638A priority patent/CN1549717B/en
Priority to PCT/EP2002/009661 priority patent/WO2003020278A1/en
Priority to MXPA04001930A priority patent/MXPA04001930A/en
Priority to CA002456127A priority patent/CA2456127C/en
Priority to PE2002000834A priority patent/PE20030772A1/en
Priority to PT02797650T priority patent/PT1423121E/en
Priority to NZ531287A priority patent/NZ531287A/en
Priority to IL16029502A priority patent/IL160295A0/en
Priority to BR0212141-7A priority patent/BR0212141A/en
Priority to ES02797650T priority patent/ES2275946T3/en
Priority to KR1020047002973A priority patent/KR100629834B1/en
Priority to DE60216122T priority patent/DE60216122T2/en
Priority to AT02797650T priority patent/ATE345136T1/en
Priority to EP02797650A priority patent/EP1423121B1/en
Priority to US10/487,741 priority patent/US7112589B2/en
Priority to HU0401431A priority patent/HUP0401431A3/en
Priority to RU2004109812/04A priority patent/RU2326119C2/en
Priority to ZA200400677A priority patent/ZA200400677B/en
Priority to CO04016657A priority patent/CO5560576A2/en
Priority to EC2004004989A priority patent/ECSP044989A/en
Priority to NO20040858A priority patent/NO20040858L/en
Priority to US11/291,007 priority patent/US20060074092A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0121026.9A 2001-08-30 2001-08-30 Organic compounds Ceased GB0121026D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB0121026.9A GB0121026D0 (en) 2001-08-30 2001-08-30 Organic compounds
ARP020103230A AR036375A1 (en) 2001-08-30 2002-08-28 PIRROLO [2,3-D] PIRIMIDINE -2- CARBONITRILE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES
RU2004109812/04A RU2326119C2 (en) 2001-08-30 2002-08-29 2-cyano-4-aminopyrimidine compounds with inhibitor action on cathepsin k, pharmaceutical compound and methods of obtaining them (alternatives)
IL16029502A IL160295A0 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidines structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
KR1020047002973A KR100629834B1 (en) 2001-08-30 2002-08-29 Cysteine Protease Inhibitors with 2-Cyano-4-amino-pyrimidine Structure and Cathepsin K Inhibitory Activity for the Treatment of Inflammations and Other Diseases
AU2002333758A AU2002333758B2 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases
CN028169638A CN1549717B (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses
PCT/EP2002/009661 WO2003020278A1 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
MXPA04001930A MXPA04001930A (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases.
CA002456127A CA2456127C (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
PE2002000834A PE20030772A1 (en) 2001-08-30 2002-08-29 PYRIMIDINE DERIVATIVES
PT02797650T PT1423121E (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
NZ531287A NZ531287A (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflamations and other diseases
PL367821A PL208280B1 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
BR0212141-7A BR0212141A (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammation and other diseases
ES02797650T ES2275946T3 (en) 2001-08-30 2002-08-29 INHIBITORS OF CYSTEINE PROTEASES WITH STRUCTURE OF 2-CYAN-4-AMINOPIRIMIDINE AND INHIBITING ACTIVITY OF CATEPSIN FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES.
JP2003524585A JP4131701B2 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitor with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for treating inflammation and other diseases
DE60216122T DE60216122T2 (en) 2001-08-30 2002-08-29 CYSTONE PROTEASE INHIBITOR WITH 2-CYANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATHEPSINE K-HEMDERING EFFECT FOR THE TREATMENT OF INFLAMMATION AND OTHER DISORDERS
AT02797650T ATE345136T1 (en) 2001-08-30 2002-08-29 CYSTEINE PROTEASE INHIBITOR WITH 2-CYANO-4-AMINO-PYRIMIDE INSTRUCTION AND CATHEPSIN-K INHIBITORY EFFECT FOR THE TREATMENT OF INFLAMMATION AND OTHER DISEASES
EP02797650A EP1423121B1 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
US10/487,741 US7112589B2 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
HU0401431A HUP0401431A3 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
ZA200400677A ZA200400677B (en) 2001-08-30 2004-01-28 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases.
CO04016657A CO5560576A2 (en) 2001-08-30 2004-02-25 CISTEINE PROTEASE INHIBITORS WITH STRUCTURE OF 2- CYAN 4-AMINO-PYRIMIDINE AND CAPTESIN K INHIBITING ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES
EC2004004989A ECSP044989A (en) 2001-08-30 2004-02-26 CISTEINE PROTEASE INHIBITORS WITH 2-CIANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATEPSIN K INHIBITOR ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES
NO20040858A NO20040858L (en) 2001-08-30 2004-02-26 Cysteine proteinase inhibitors with 2-cyano-4-aminopyrimidine structure and cathepsin K inhibitor activity for the treatment of inflammation and other diseases
US11/291,007 US20060074092A1 (en) 2001-08-30 2005-11-30 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0121026.9A GB0121026D0 (en) 2001-08-30 2001-08-30 Organic compounds

Publications (1)

Publication Number Publication Date
GB0121026D0 true GB0121026D0 (en) 2001-10-24

Family

ID=9921227

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0121026.9A Ceased GB0121026D0 (en) 2001-08-30 2001-08-30 Organic compounds

Country Status (4)

Country Link
EC (1) ECSP044989A (en)
GB (1) GB0121026D0 (en)
NO (1) NO20040858L (en)
ZA (1) ZA200400677B (en)

Also Published As

Publication number Publication date
NO20040858L (en) 2004-05-21
ECSP044989A (en) 2004-04-28
ZA200400677B (en) 2004-12-08

Similar Documents

Publication Publication Date Title
GB0108876D0 (en) Organic Compounds
GB0103389D0 (en) Organic compounds
GB0108606D0 (en) Organic compounds
GB0108337D0 (en) Organic compounds
GB0103303D0 (en) Organic compounds
GB0108087D0 (en) Organic compounds
GB0107368D0 (en) Organic compounds
GB0103258D0 (en) Organic compounds
GB0101598D0 (en) Organic compounds
GB0102841D0 (en) Organic compounds
GB0107365D0 (en) Organic compounds
GB0106432D0 (en) Organic compounds
GB0104070D0 (en) Organic compounds
GB0108091D0 (en) Organic compounds
GB0108089D0 (en) Organic compounds
GB0108095D0 (en) Organic compounds
GB0107508D0 (en) Organic compounds
GB0107507D0 (en) Organic compounds
GB0107506D0 (en) Organic compounds
GB0107505D0 (en) Organic compounds
GB0107371D0 (en) Organic compounds
GB0108098D0 (en) Organic compounds
GB0108100D0 (en) Organic compounds
GB0106652D0 (en) Organic compounds
GB0101023D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)